RAP 0.00% 20.5¢ resapp health limited

Ann: Further Positive Preliminary Results from Clinical Study, page-23

  1. 1,285 Posts.
    lightbulb Created with Sketch. 63
    You really can't get better results than these which improve on previous results, expand on previous results, answer more questions, validate and provide a great platform to make this app into a truly revolutionary piece of technology which is a game changer. By the end of next year RAP should have a robust pretty much foolproof diagnosis tool for respiratory illnesses.
 
watchlist Created with Sketch. Add RAP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.